Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors B Chertok, BA Moffat, AE David, F Yu, C Bergemann, BD Ross, VC Yang Biomaterials 29 (4), 487-496, 2008 | 1133 | 2008 |
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response BA Moffat, TL Chenevert, TS Lawrence, CR Meyer, TD Johnson, Q Dong, ... Proceedings of the national academy of sciences 102 (15), 5524-5529, 2005 | 800 | 2005 |
Vascular targeted nanoparticles for imaging and treatment of brain tumors GR Reddy, MS Bhojani, P McConville, J Moody, BA Moffat, DE Hall, ... Clinical Cancer Research 12 (22), 6677-6686, 2006 | 615 | 2006 |
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma DA Hamstra, TL Chenevert, BA Moffat, TD Johnson, CR Meyer, ... Proceedings of the National Academy of Sciences 102 (46), 16759-16764, 2005 | 372 | 2005 |
Evaluation of cancer therapy using diffusion magnetic resonance imaging BD Ross, BA Moffat, TS Lawrence, SK Mukherji, SS Gebarski, DJ Quint, ... Molecular cancer therapeutics 2 (6), 581-587, 2003 | 318 | 2003 |
Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity TJ Oxley, NL Opie, SE John, GS Rind, SM Ronayne, TL Wheeler, JW Judy, ... Nature Biotechnology, 2016 | 282 | 2016 |
Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer R Kopelman, YEL Koo, M Philbert, BA Moffat, GR Reddy, P McConville, ... Journal of Magnetism and Magnetic Materials 293 (1), 404-410, 2005 | 232 | 2005 |
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome BA Moffat, TL Chenevert, CR Meyer, PE Mckeever, DE Hall, BA Hoff, ... Neoplasia 8 (4), 259-267, 2006 | 230 | 2006 |
A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI BA Moffat, GR Reddy, P McConville, DE Hall, TL Chenevert, ... Molecular imaging 2 (4), 15353500200303163, 2003 | 206 | 2003 |
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy TL Chenevert, CR Meyer, BA Moffat, A Rehemtulla, SK Mukherji, ... Molecular imaging 1 (4), 15353500200221482, 2002 | 176 | 2002 |
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of … CJ Galbán, SK Mukherji, TL Chenevert, CR Meyer, DA Hamstra, ... Translational oncology 2 (3), 184-190, 2009 | 168 | 2009 |
Diffusion imaging for evaluation of tumor therapies in preclinical animal models BA Moffat, DE Hall, J Stojanovska, PJ McConville, JB Moody, ... Magnetic Resonance Materials in Physics, Biology and Medicine 17, 249-259, 2004 | 160 | 2004 |
Age-related changes in refractive index distribution and power of the human lens as measured by magnetic resonance micro-imaging in vitro BA Moffat, DA Atchison, JM Pope Vision research 42 (13), 1683-1693, 2002 | 157 | 2002 |
Age-related changes in the kinetics of water transport in normal human lenses BA Moffat, KA Landman, RJW Truscott, MHJ Sweeney, JM Pope Experimental eye research 69 (6), 663-669, 1999 | 157 | 1999 |
Comparative study of the magnetic behavior of spherical and cubic superparamagnetic iron oxide nanoparticles G Zhen, BW Muir, BA Moffat, P Harbour, KS Murray, B Moubaraki, ... The Journal of Physical Chemistry C 115 (2), 327-334, 2011 | 147 | 2011 |
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy KC Lee, BA Moffat, AF Schott, R Layman, S Ellingworth, R Juliar, AP Khan, ... Clinical cancer research 13 (2), 443-450, 2007 | 127 | 2007 |
Systematic review: quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases P Ravanfar, SM Loi, WT Syeda, TE Van Rheenen, AI Bush, P Desmond, ... Frontiers in neuroscience 15, 618435, 2021 | 118 | 2021 |
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies DA Hamstra, KC Lee, JM Tychewicz, VD Schepkin, BA Moffat, M Chen, ... Molecular Therapy 10 (5), 916-928, 2004 | 116 | 2004 |
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker DE Hall, BA Moffat, J Stojanovska, TD Johnson, Z Li, DA Hamstra, ... Clinical cancer research 10 (23), 7852-7859, 2004 | 106 | 2004 |
A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information CR Meyer, BA Moffat, KK Kuszpit, PL Bland, PE Mckeever, TD Johnson, ... Molecular imaging 5 (1), 7290.2006. 00002, 2006 | 93 | 2006 |